TREATMENT OF HYPERLIPOPROTEINEMIA TYPE-IIA WITH A PRUDENT DIET AND CLOFIBRATE

被引:0
|
作者
MERTZ, DP [1 ]
SUERMANN, J [1 ]
机构
[1] KURKLIN PK, POSTFACH 2340, D-4934 HORN BAD MEINBERG, FED REP GER
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:867 / 873
页数:7
相关论文
共 50 条
  • [31] EFFECT OF BETA-PYRIDYLCARBINOL ON LIPIDS AND LIPOPROTEINS IN PRIMARY HYPERLIPOPROTEINEMIA TYPE-IIA
    HUTT, V
    WECHSLER, JG
    KLOR, HU
    DITSCHUNEIT, H
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1983, 33-2 (12): : 1682 - 1684
  • [32] PLATELET MEMBRANE FLUIDITY IN TYPE-IIA, TYPE-IIB AND TYPE-IV HYPERLIPOPROTEINEMIA
    MALLE, E
    SATTLER, W
    PRENNER, E
    LEIS, HJ
    KARADI, I
    KNIPPING, G
    ROMICS, L
    KOSTNER, GM
    ATHEROSCLEROSIS, 1991, 87 (2-3) : 159 - 167
  • [33] FAMILIAL HYPERCHOLESTEROLEMIA - REPORT OF A FAMILY WITH TYPICAL HYPERLIPOPROTEINEMIA TYPE-IIA AND FAVORABLE COURSE
    PAVONE, L
    LAROSA, M
    FIUMARA, A
    RIESEN, W
    MORDASINI, R
    RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1983, 9 (02): : 135 - 138
  • [34] EFFECT OF BETA-PYRIDYLCARBINOL ON LIPOPROTEIN LIPIDS IN PRIMARY TYPE-IIA HYPERLIPOPROTEINEMIA
    SCHWANDT, P
    WEISWEILER, P
    NEUREUTHER, G
    ATHEROSCLEROSIS, 1979, 34 (01) : 35 - 39
  • [35] THE HYPOLIPIDEMIC ACTION OF PROBUCOL - DRUG TRANSPORT AND LIPOPROTEIN COMPOSITION IN TYPE-IIA HYPERLIPOPROTEINEMIA
    DACHET, C
    JACOTOT, B
    BUXTORF, JC
    ATHEROSCLEROSIS, 1985, 58 (1-3) : 261 - 268
  • [36] LONG-TERM STUDY WITH ETOFIBRATE IN PATIENTS WITH HYPERLIPOPROTEINEMIA TYPE-IIA AND IIB
    SPOTTL, F
    FROSCHAUER, J
    HAASE, W
    HERZ KREISLAUF, 1976, 8 (12): : 710 - 714
  • [37] TYPE-IIA HYPERLIPOPROTEINEMIA AND HLA-A AND HLA-B ANTIGENS - NO ASSOCIATION
    DUFOSSE, F
    FERRAZ, ME
    GOUDEMAND, J
    ROUGET, JP
    DEWAILLY, P
    JAILLARD, J
    TISSUE ANTIGENS, 1984, 23 (04): : 246 - 249
  • [38] DOSAGE-ACTIVITY COMPARISON WITH ETIROXATE HCL IN HYPERLIPOPROTEINEMIA TYPE-IIA AND TYPE-IIB
    BANZ, H
    GALL, FP
    MEDIZINISCHE KLINIK, 1980, 75 (01) : 51 - 52
  • [39] STUDIES ON PHYSICAL AND CHEMICAL CHARACTERIZATION OF PLASMA LIPOPROTEIN SYSTEM IN PATIENTS WITH TYPE-IIA HYPERLIPOPROTEINEMIA
    LEE, DM
    CIRCULATION, 1974, 50 (04) : 267 - 267
  • [40] DRUG PLASMA-LEVELS AND HYPOCHOLESTEROLEMIC EFFECT OF FENOFIBRATE IN PATIENTS WITH TYPE-IIA HYPERLIPOPROTEINEMIA
    DROUIN, P
    MEJEAN, L
    LAMBERT, D
    SAUVANET, JP
    DEBRY, G
    TOURNE, C
    WULFERT, E
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1979, 26 (03): : 357 - 362